Irritable Bowel Syndrome and Digestive Health Support Forum banner

Yahoo- Gilead Sciences to present Viread Phase III clinical trial data (News-Medical-Net)

435 Views 0 Replies 1 Participant Last post by  VSsupport
Gilead Sciences, Inc. today announced the presentation of three-year (144-week) open label data from two pivotal Phase III clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread® (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) infection.View the full article
1 - 1 of 1 Posts
1 - 1 of 1 Posts
This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.